Several distinct molecular subtypes, each associated with different clinical outcomes, have been identified by array and RNA-seq studies, and include: Luminal A and B, ERBB2 overexpression (the gene for the HER2/Neu protein), and normal breast-like and basal-like breast cancers (BLBCs) [2,3]. Here, ERBB2 is linked to breast cancer.